Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (191-200 of 8,369) with videos related to

Pageof 837
Sort By:
Drugs|January 1, 1987
Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospectsC U Tuazon, A M Labriola
Drugs|January 1, 1985
Influence of temocillin on colonisation resistance and consequences for therapyH G De Vries-Hospers, W Hofstra, G W Welling, et al.
Drugs|January 1, 1985
A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibioticsJ Focht, H D Heilmann, S Heinrich, et al.
Drugs|February 26, 2022
Correction to: Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical IssuesMichael Weightman, Ranjit Kini, Robert Parker, et al.
Drugs|January 1, 1988
Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A reviewB Dahlöf
Drugs|May 16, 2018
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular HypertensionSheridan M Hoy
Drugs|September 6, 2024
Correction: Elafibranor: First ApprovalHannah A Blair
Drugs|November 23, 2023
Motixafortide: First ApprovalSheridan M Hoy
Drugs|November 4, 2023
Elranatamab: First ApprovalSohita Dhillon
Drugs|August 28, 2023
Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled TrialsHuilei Zhao, Yang Liu, Menglu Liu, et al.
Pageof 837

Showing results (191-200 of 8,369) with videos related to

Sort By:
Pageof 837
Drugs|January 1, 1987
Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospectsC U Tuazon, A M Labriola
Drugs|January 1, 1985
Influence of temocillin on colonisation resistance and consequences for therapyH G De Vries-Hospers, W Hofstra, G W Welling, et al.
Drugs|January 1, 1985
A survey of temocillin sensitivity of strains resistant to newer beta-lactam antibioticsJ Focht, H D Heilmann, S Heinrich, et al.
Drugs|February 26, 2022
Correction to: Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical IssuesMichael Weightman, Ranjit Kini, Robert Parker, et al.
Drugs|January 1, 1988
Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A reviewB Dahlöf
Drugs|May 16, 2018
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular HypertensionSheridan M Hoy
Drugs|September 6, 2024
Correction: Elafibranor: First ApprovalHannah A Blair
Drugs|November 23, 2023
Motixafortide: First ApprovalSheridan M Hoy
Drugs|November 4, 2023
Elranatamab: First ApprovalSohita Dhillon
Drugs|August 28, 2023
Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled TrialsHuilei Zhao, Yang Liu, Menglu Liu, et al.
Pageof 837